We have observed
8 EP applications
Gillian Margaret McGuire
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
INHIBITORS OF C-FMS KINASE
LACTAM KINASE INHIBITORS
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS,
PROCESSES FOR THE PREPARATION OF A DIARYLTHIOHYDANTOIN COMPOUND
NANOLAMINATED 2-2-1 MAX-PHASE COMPOSITIONS
SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE